Effective and Safe Combination Therapy for Severe Acne Vulgaris: A Randomized, Vehicle-Controlled, Double-blind Study of Adapalene 0.1%–Benzoyl Peroxide 2.5% Fixed-Dose Combination Gel With Doxycycline Hyclate 100 mg

Article Type
Article
Changed
Thu, 01/10/2019 - 12:19
Display Headline
Effective and Safe Combination Therapy for Severe Acne Vulgaris: A Randomized, Vehicle-Controlled, Double-blind Study of Adapalene 0.1%–Benzoyl Peroxide 2.5% Fixed-Dose Combination Gel With Doxycycline Hyclate 100 mg
Author(s)
Stein Gold L
Cruz A
Eichenfield L
Tan J
Jorizzo J
Kerrouche N
Dhuin J-C

Article PDF
085020094.pdf
Author and Disclosure Information

Stein Gold L, Cruz A, Eichenfield L, Tan J, Jorizzo J, Kerrouche N, Dhuin J-C

Issue
Cutis - 85(2)
Publications
Cutis
MDedge Dermatology
Topics
Acne
Page Number
94-104
Sections
Original Research
Author(s)
Stein Gold L
Cruz A
Eichenfield L
Tan J
Jorizzo J
Kerrouche N
Dhuin J-C
Author(s)
Stein Gold L
Cruz A
Eichenfield L
Tan J
Jorizzo J
Kerrouche N
Dhuin J-C
Author and Disclosure Information

Stein Gold L, Cruz A, Eichenfield L, Tan J, Jorizzo J, Kerrouche N, Dhuin J-C

Author and Disclosure Information

Stein Gold L, Cruz A, Eichenfield L, Tan J, Jorizzo J, Kerrouche N, Dhuin J-C

Article PDF
085020094.pdf
Article PDF
085020094.pdf

Issue
Cutis - 85(2)
Issue
Cutis - 85(2)
Page Number
94-104
Page Number
94-104
Publications
Cutis
MDedge Dermatology
Publications
Cutis
MDedge Dermatology
Topics
Acne
Article Type
Article
Display Headline
Effective and Safe Combination Therapy for Severe Acne Vulgaris: A Randomized, Vehicle-Controlled, Double-blind Study of Adapalene 0.1%–Benzoyl Peroxide 2.5% Fixed-Dose Combination Gel With Doxycycline Hyclate 100 mg
Display Headline
Effective and Safe Combination Therapy for Severe Acne Vulgaris: A Randomized, Vehicle-Controlled, Double-blind Study of Adapalene 0.1%–Benzoyl Peroxide 2.5% Fixed-Dose Combination Gel With Doxycycline Hyclate 100 mg
Sections
Original Research
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

One-Week Treatment With Once-Daily Fluorouracil Cream 0.5% in Participants With Actinic Keratoses

Article Type
Article
Changed
Thu, 01/10/2019 - 12:15
Display Headline
One-Week Treatment With Once-Daily Fluorouracil Cream 0.5% in Participants With Actinic Keratoses
Author(s)
Menter A
Vamvakias G
Jorizzo J

Article PDF
081060509.pdf
Author and Disclosure Information

Menter A, Vamvakias G, Jorizzo J

Issue
Cutis - 81(6)
Publications
Cutis
MDedge Dermatology
Topics
Actinic Keratosis
Nonmelanoma Skin Cancer
Page Number
509-516
Sections
Original Research
Author(s)
Menter A
Vamvakias G
Jorizzo J
Author(s)
Menter A
Vamvakias G
Jorizzo J
Author and Disclosure Information

Menter A, Vamvakias G, Jorizzo J

Author and Disclosure Information

Menter A, Vamvakias G, Jorizzo J

Article PDF
081060509.pdf
Article PDF
081060509.pdf

Issue
Cutis - 81(6)
Issue
Cutis - 81(6)
Page Number
509-516
Page Number
509-516
Publications
Cutis
MDedge Dermatology
Publications
Cutis
MDedge Dermatology
Topics
Actinic Keratosis
Nonmelanoma Skin Cancer
Article Type
Article
Display Headline
One-Week Treatment With Once-Daily Fluorouracil Cream 0.5% in Participants With Actinic Keratoses
Display Headline
One-Week Treatment With Once-Daily Fluorouracil Cream 0.5% in Participants With Actinic Keratoses
Sections
Original Research
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

The Safety and Efficacy of Sertaconazole Nitrate Cream 2% for Tinea Pedis

Article Type
Article
Changed
Thu, 01/10/2019 - 12:08
Display Headline
The Safety and Efficacy of Sertaconazole Nitrate Cream 2% for Tinea Pedis
Author(s)
Savin R
Jorizzo J

Article PDF
078040268.pdf
Author and Disclosure Information

Savin R, Jorizzo J

Issue
Cutis - 78(4)
Publications
Cutis
MDedge Dermatology
Page Number
268-274
Sections
Original Research
Author(s)
Savin R
Jorizzo J
Author(s)
Savin R
Jorizzo J
Author and Disclosure Information

Savin R, Jorizzo J

Author and Disclosure Information

Savin R, Jorizzo J

Article PDF
078040268.pdf
Article PDF
078040268.pdf

Issue
Cutis - 78(4)
Issue
Cutis - 78(4)
Page Number
268-274
Page Number
268-274
Publications
Cutis
MDedge Dermatology
Publications
Cutis
MDedge Dermatology
Article Type
Article
Display Headline
The Safety and Efficacy of Sertaconazole Nitrate Cream 2% for Tinea Pedis
Display Headline
The Safety and Efficacy of Sertaconazole Nitrate Cream 2% for Tinea Pedis
Sections
Original Research
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Randomized Trial Evaluating a New 0.5% Fluorouracil Formulation Demonstrates Efficacy After 1-, 2-, or 4-Week Treatment in Patients With Actinic Keratosis

Article Type
Article
Changed
Thu, 01/10/2019 - 11:57
Display Headline
Randomized Trial Evaluating a New 0.5% Fluorouracil Formulation Demonstrates Efficacy After 1-, 2-, or 4-Week Treatment in Patients With Actinic Keratosis
Author(s)
Jorizzo J
Stewart D
Bucko A
Davis SA
Espy P
Hino P
Rodriguez D
Savin R
Stough D
Furst K
Connolly M
Levy S

Article PDF
070060335.pdf
Author and Disclosure Information

Jorizzo J, Stewart D, Bucko A, Davis SA, Espy P, Hino P, Rodriguez D, Savin R, Stough D, Furst K, Connolly M, Levy S

Issue
Cutis - 70(6)
Publications
Cutis
MDedge Dermatology
Topics
Nonmelanoma Skin Cancer
Melanoma
Page Number
335-339
Sections
Original Research
Author(s)
Jorizzo J
Stewart D
Bucko A
Davis SA
Espy P
Hino P
Rodriguez D
Savin R
Stough D
Furst K
Connolly M
Levy S
Author(s)
Jorizzo J
Stewart D
Bucko A
Davis SA
Espy P
Hino P
Rodriguez D
Savin R
Stough D
Furst K
Connolly M
Levy S
Author and Disclosure Information

Jorizzo J, Stewart D, Bucko A, Davis SA, Espy P, Hino P, Rodriguez D, Savin R, Stough D, Furst K, Connolly M, Levy S

Author and Disclosure Information

Jorizzo J, Stewart D, Bucko A, Davis SA, Espy P, Hino P, Rodriguez D, Savin R, Stough D, Furst K, Connolly M, Levy S

Article PDF
070060335.pdf
Article PDF
070060335.pdf

Issue
Cutis - 70(6)
Issue
Cutis - 70(6)
Page Number
335-339
Page Number
335-339
Publications
Cutis
MDedge Dermatology
Publications
Cutis
MDedge Dermatology
Topics
Nonmelanoma Skin Cancer
Melanoma
Article Type
Article
Display Headline
Randomized Trial Evaluating a New 0.5% Fluorouracil Formulation Demonstrates Efficacy After 1-, 2-, or 4-Week Treatment in Patients With Actinic Keratosis
Display Headline
Randomized Trial Evaluating a New 0.5% Fluorouracil Formulation Demonstrates Efficacy After 1-, 2-, or 4-Week Treatment in Patients With Actinic Keratosis
Sections
Original Research
Article Source

PURLs Copyright

Inside the Article

Article PDF Media
Subscribe to Jorizzo J